Zacks Investment Research Lowers Omega Healthcare Investors (OHI) to Hold
Omega Healthcare Investors (NYSE:OHI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday.
According to Zacks, “Omega Healthcare Investors, Inc. was incorporated in the State of Maryland. It is a self-administered real estate investment trust (REIT), investing in income producing healthcare facilities, principally long-term care facilities located in the United States (U.S.) and the United Kingdom (U.K.). The Company provide lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs) and, to a lesser extent, assisted living facilities (ALFs), independent living facilities and rehabilitation and acute care facilities. It has historically financed investments through borrowings under its revolving credit facilities, private placements or public offerings of its debt and equity securities, the assumption of secured indebtedness, retention of cash flow, or a combination of these methods. “
A number of other equities research analysts have also recently commented on OHI. Stifel Nicolaus cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 price target on the stock. in a report on Thursday, February 7th. Scotiabank began coverage on shares of Omega Healthcare Investors in a report on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 price target on the stock. ValuEngine raised shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Tuesday, November 20th. Bank of America reaffirmed a “hold” rating on shares of Omega Healthcare Investors in a report on Monday, November 19th. Finally, lifted their price target on shares of Omega Healthcare Investors to $34.00 and gave the stock a “neutral” rating in a report on Monday, November 5th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $34.44.
In other Omega Healthcare Investors news, insider Steven J. Insoft sold 50,000 shares of the business’s stock in a transaction on Thursday, January 31st. The shares were sold at an average price of $40.00, for a total transaction of $2,000,000.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Michael Ritz sold 6,000 shares of the business’s stock in a transaction on Friday, November 16th. The shares were sold at an average price of $34.75, for a total transaction of $208,500.00. Following the sale, the insider now directly owns 10,076 shares in the company, valued at approximately $350,141. The disclosure for this sale can be found here. Insiders have sold a total of 86,000 shares of company stock worth $3,321,750 in the last three months. Insiders own 1.65% of the company’s stock.
A number of hedge funds have recently modified their holdings of the business. Green Street Investors LLC purchased a new position in shares of Omega Healthcare Investors during the 3rd quarter valued at $5,224,000. Morgan Stanley grew its position in shares of Omega Healthcare Investors by 2.4% during the 3rd quarter. Morgan Stanley now owns 1,017,075 shares of the real estate investment trust’s stock valued at $33,329,000 after purchasing an additional 23,415 shares in the last quarter. Stratos Wealth Partners LTD. purchased a new position in shares of Omega Healthcare Investors during the 3rd quarter valued at $132,000. Lincoln National Corp purchased a new position in shares of Omega Healthcare Investors during the 3rd quarter valued at $222,000. Finally, Global Endowment Management LP purchased a new position in shares of Omega Healthcare Investors during the 3rd quarter valued at $1,613,000. 72.74% of the stock is currently owned by institutional investors and hedge funds.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Balanced Fund
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.